ClinicalTrials.Veeva

Menu

Lung Cancer and Idiopathic Pulmonary Fibrosis : Pathological and Molecular Characterization (K-FPI)

A

Assistance Publique - Hôpitaux de Paris

Status

Unknown

Conditions

Lung Cancer and Idiopathic Pulmonary Fibrosis

Study type

Observational

Funder types

Other

Identifiers

NCT03486262
NI16034

Details and patient eligibility

About

Retrospective inclusion of lung cancers developed in a context of idiopathic pulmonary fibrosis, diagnosed and / or treated in participating centers. The cases are recovered retrospectively from the records of the pulmonology and pathology departments of our various partners.

Full description

Primary objective:

Characterize altered molecular pathways in lung cancer in patients with IPF versus lung cancer in non-IPF patients.

Secondary objectives:

Identify specific therapeutic targets Describe a cohort of lung cancers on IPF (clinical / radiological and pathological data) To study the relationship between neoplastic / preneoplastic lesions and pulmonary parenchyma reshaped by fibrosis.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Lung carcinoma
  • Idiopathic pulmonary fibrosis

Exclusion criteria

  • No tumor sample available

Trial design

100 participants in 1 patient group

Lung carcinoma on IPF
Description:
Lung carcinoma on IPF

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems